Eton Pharmaceuticals, Inc. (ETON) — Financial statements
Income statement, balance sheet, and cash flow for Eton Pharmaceuticals, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 80↑104.9% | 39↑23.3% | 32↑48.9% | 21↓2.7% | 22 | |
| Cost of Revenue | 37↑138.5% | 16↑47.4% | 11↑52.6% | 7↑164.3% | 3 | |
| Gross Profit | 43↑82.6% | 23↑11.2% | 21↑47.1% | 14↓25.5% | 19 | |
| Operating Expenses | ||||||
| R&D Expenses | 8↑138.6% | 3↓2.0% | 3↓16.9% | 4↓35.9% | 6 | |
| General & Administrative Expenses | 36↑57.4% | 23↑20.2% | 19↑1.9% | 19↑28.4% | 14 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 36↑57.4% | 23↑20.2% | 19↑1.9% | 19↑28.4% | 14 | |
| Other Expenses | -0.92 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 43↑64.1% | 26↑16.9% | 22↓1.4% | 23↑9.1% | 21 | |
| Total Costs & Expenses | 80↑92.0% | 42↑26.7% | 33↑11.3% | 30↑26.5% | 23 | |
| Operating Results | ||||||
| Operating Income | 0.07↑102.8% | -3↓117.9% | -1↑85.6% | -8↓452.5% | -1 | |
| Depreciation & Amortization | 4↑252.9% | 1↑27.2% | 0.90↓49.2% | 2↑284.0% | 0.46 | |
| EBITDA | 4↑383.7% | -1↓398.6% | -0.29↑95.5% | -6↓527.9% | -1 | |
| EBIT | 0.07↑102.8% | -3↓117.9% | -1↑85.6% | -8↓452.5% | -1 | |
| Interest & Other Income | ||||||
| Net Interest Income | -5↓138.5% | -2 | 0.00 | 0.00 | 0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 5↑138.5% | 2 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | -5↓282.3% | -1↓340.8% | 0.50↑166.1% | -0.76↓65.4% | -0.46 | |
| Income Before Tax | -5↓19.7% | -4↓452.7% | -0.69↑92.4% | -9↓361.4% | -2 | |
| Income Tax Expense | 0.04↑186.7% | 0.02↓93.9% | 0.25 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -5↓20.4% | -4↓308.4% | -0.94↑89.6% | -9↓361.4% | -2 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -5↓20.4% | -4↓308.4% | -0.94↑89.6% | -9↓361.4% | -2 | |
| Bottom-Line Net Income | -5↓20.4% | -4↓308.4% | -0.94↑89.6% | -9↓361.4% | -2 | |
| EPS (Basic) | -0.17↓13.3% | -0.15↓311.0% | -0.04↑89.9% | -0.36↓363.9% | -0.08 | |
| EPS (Diluted) | -0.17↓13.3% | -0.15↓311.0% | -0.04↑89.9% | -0.36↓363.9% | -0.08 | |
| Weighted Average Shares | 27↑3.9% | 26↑1.0% | 26↑2.0% | 25↓0.2% | 25 | |
| Weighted Average Diluted Shares | 27↑3.9% | 26↑1.0% | 26↑2.0% | 25↓0.2% | 25 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.